Objective GI is a clinical research company, launched in 2018 by Colleen Hoke and Don Lazas, MD, whom both recognized a need for high quality, consistent and efficient research programs. The company establishes partnerships with gastroenterology medical practices, providing research infrastructure, optimal trial selection, study implementation and key personnel management to clinical studies. Objective GI's proprietary processes and technology eliminate the healthcare workflow disruptions typically associated with clinical trials.
